The Johnson & Johnson COVID-19 Vaccine: What You Need to Know
From the Everyday Health website
At the end of February, Americans received a new weapon in the fight against the coronavirus when the U.S. Food and Drug Administration (FDA) granted emergency use authorization for a new COVID-19 vaccine, by Johnson & Johnson’s vaccine subsidiary, Janssen.
Just days after this decision, President Joe Biden announced that his Administration had helped forge a historic manufacturing collaboration between Johnson & Johnson (J&J) and one of its competitors, Merck. Under the arrangement, Merck will dedicate two facilities in the United States to making the J&J vaccine.
Retiree News 
Comments are closed.